Skip Navigation

Coronavirus (COVID-19) information for Dana-Farber patients & families Learn more

News Releases & Announcements

Filter Results

1349 News Releases Found

Cigall Kadoch, PhD
News Releases
3/20/2023

Researchers Identify Key Source of T Cell “Exhaustion”

  • CAR T-Cell Therapy
_
News Releases
3/20/2023

Cancer diagnostic services in a community health center speed diagnosis for underserved populations

  • Inclusion, Diversity & Equity
Microscopic image of colon cancer. Photo: OGPhoto via Canva.Com
News Releases
3/16/2023

Dana-Farber researchers chart a course for understanding, preventing, and treating young-onset colorectal cancer

  • Research
  • Rectal Cancer
  • Colon Cancer
Scott A. Armstrong, MD, PhD
News Releases
3/15/2023

Study Unravels a Cause of Resistance to Novel Drug in Patients with Acute Leukemia

  • Research
  • Leukemias
  • Blood Cancer
Geoffrey Shapiro, MD, PhD
News Releases
3/14/2023

Novobiocin Attacks BRCA-Mutated Cancer Cells from Within and Without, Study Shows

  • Research
Cigall Kadoch, PhD
News Releases
3/9/2023

New Class of Drugs May Prevent Infection by Wide Range of COVID-19 Variant

Krietta Bowens Jones
News Releases
3/1/2023

Krietta Bowens Jones is a Massachusetts Lawyers Weekly In-House Leader for 2023

Dana-Farber Cancer Institute lit up blue in honor of colorectal cancer awareness.
News Releases
3/1/2023

Studies of novel therapeutic approaches highlighted during Colorectal Cancer Awareness Month at Dana-Farber

  • CAR T-Cell Therapy
  • Research
  • Immunotherapy
  • Rectal Cancer
  • Colon Cancer
Sara M. Tolaney, MD, MPH
News Releases
2/28/2023

Therapy for small, HER2-positive breast tumors continues to be highly effective after 10 years, study finds

  • Breast Cancer
The phase 3 CLEAR study results showed significant benefits in patients with advanced renal cell carcinoma (kidney cancer) from the combination comprised of lenvatinib, and pembrolizumab.
News Releases
2/27/2023

Immunotherapy – targeted drug combination improves survival in advanced kidney cancer

  • Research
  • Kidney Cancer
3D print of a SARS-CoV-2—also known as 2019-nCoV, the virus that causes COVID-19—virus particle. Credit - NIH
News Releases
2/17/2023

Three doses of COVID-19 mRNA vaccine associated with better outcomes for patients with cancer

  • Research